Skip to main content

Research Repository

Advanced Search

SCENIC: Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study with Inhaled RVT-1601 for the Treatment of Persistent Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF)

People Involved

Project Acronym SCENIC
Status Project Complete
Funder(s) Hull University Teaching Hospitals NHS Trust
Value £17,918.00
Project Dates May 1, 2019 - Jan 31, 2022
Partner Organisations 00 No Partners

You might also like

MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness Mar 1, 2019 - Feb 29, 2024
A parallel group, double-blind, randomised placebo-controlled trial comparing the efficacy and cost effectiveness of low dose oral modified release morphine (MRM) versus placebo on the intensity of breathlessness and daily activity in people with c... Read More about MABEL: A Parallel Group, Double-blind, Randomised Placebo-controlled Trial Comparing The Efficacy And Cost effectiveness.